ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 97 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,986,799 | -20.2% | 297,425 | +0.3% | 0.00% | – |
| Q2 2023 | $2,489,119 | +57.2% | 296,677 | +86.1% | 0.00% | – |
| Q1 2023 | $1,583,398 | +160.0% | 159,456 | +82.3% | 0.00% | – |
| Q4 2022 | $608,937 | +7.2% | 87,491 | -17.9% | 0.00% | – |
| Q3 2022 | $568,000 | +7.4% | 106,506 | -19.7% | 0.00% | – |
| Q2 2022 | $529,000 | +30.3% | 132,609 | +45.3% | 0.00% | – |
| Q1 2022 | $406,000 | -69.7% | 91,293 | -72.7% | 0.00% | – |
| Q4 2021 | $1,340,000 | +63.8% | 334,889 | +259.9% | 0.00% | – |
| Q3 2021 | $818,000 | -26.5% | 93,054 | -5.3% | 0.00% | – |
| Q2 2021 | $1,113,000 | +172.8% | 98,265 | +186.3% | 0.00% | – |
| Q1 2021 | $408,000 | +700.0% | 34,322 | +359.5% | 0.00% | – |
| Q4 2020 | $51,000 | +4.1% | 7,469 | -35.9% | 0.00% | – |
| Q2 2020 | $49,000 | +88.5% | 11,659 | +10.1% | 0.00% | – |
| Q1 2020 | $26,000 | -62.9% | 10,589 | -11.9% | 0.00% | – |
| Q4 2019 | $70,000 | -5.4% | 12,013 | -13.8% | 0.00% | – |
| Q3 2019 | $74,000 | +8.8% | 13,933 | +24.5% | 0.00% | – |
| Q2 2019 | $68,000 | +25.9% | 11,188 | +87.7% | 0.00% | – |
| Q1 2019 | $54,000 | -47.1% | 5,959 | -51.1% | 0.00% | – |
| Q4 2018 | $102,000 | +45.7% | 12,181 | +139.4% | 0.00% | – |
| Q3 2018 | $70,000 | +191.7% | 5,088 | +64.2% | 0.00% | – |
| Q2 2018 | $24,000 | -31.4% | 3,098 | -32.9% | 0.00% | – |
| Q1 2018 | $35,000 | +45.8% | 4,615 | +31.9% | 0.00% | – |
| Q4 2017 | $24,000 | -55.6% | 3,500 | -53.3% | 0.00% | – |
| Q3 2017 | $54,000 | +28.6% | 7,500 | -16.7% | 0.00% | – |
| Q2 2017 | $42,000 | +5.0% | 9,000 | +12.5% | 0.00% | – |
| Q1 2017 | $40,000 | +25.0% | 8,000 | +33.3% | 0.00% | – |
| Q4 2016 | $32,000 | +3.2% | 6,000 | +50.0% | 0.00% | – |
| Q3 2016 | $31,000 | +72.2% | 4,000 | +22.9% | 0.00% | – |
| Q2 2016 | $18,000 | +125.0% | 3,254 | +62.7% | 0.00% | – |
| Q1 2016 | $8,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
| Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
| Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
| Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
| Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
| Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
| Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
| Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
| APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |